多中心起始系统性红斑狼疮队列中动脉粥样硬化性血管事件的累积
本研究在33个中心、1999–2017年每年随访的SLE起始队列中,1,710例有至少一次随访(共13,666患者年),3.6%发生至少一次归因于动脉粥样硬化的血管事件(AVE),事件率4.6/1,000患者年;抗疟药治疗与较低AVE率相关,既往血管事件和BMI>40 kg/m2与较高AVE率相关。
要点
- SLE起始队列中AVE事件率为4.6/1,000患者年,3.6%患者发生至少一次AVE。
- 抗疟药治疗与较低AVE率相关(HR 0.54,95%CI 0.32–0.91)。
- 既往血管事件(HR 4.00)和BMI>40 kg/m2(HR 2.74)与较高AVE率相关。
核心结论
- 本队列中AVE患病率与累积率明显低于既往发表数据,可能与疾病活动和经典危险因素控制更好有关。
研究设计与样本
- 33中心SLE起始队列,1999–2017年每年随访,1,848例入组,1,710例有至少一次随访,共13,666患者年。
主要发现
- 1,710例中3.6%发生至少一次归因于动脉粥样硬化的AVE,事件率4.6/1,000患者年。
- 多变量分析中抗疟药治疗与较低AVE率相关(HR 0.54,95%CI 0.32–0.91)。
- 任何既往血管事件(HR 4.00,95%CI 1.55–10.30)和BMI>40 kg/m2(HR 2.74,95%CI 1.04–7.18)与较高AVE率相关。
- 既往AVE增加后续AVE风险(HR 5.42,95%CI 3.17–9.27,P<0.001)。
关键数值与推荐
- AVE归因于动脉粥样硬化基于事件时SLE不活动、影像或病理报告典型动脉粥样硬化改变和/或他处动脉粥样硬化证据。
临床怎么用
- 对SLE患者应重视抗疟药治疗及经典心血管危险因素(尤其肥胖)管理以降低AVE风险。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: In previous studies, atherosclerotic vascular events (AVEs) were shown to occur in ~10% of patients with systemic lupus erythematosus (SLE). We undertook this study to investigate the annual occurrence and potential risk factors for AVEs in a multinational, multiethnic inception cohort of patients with SLE. METHODS: A large 33-center cohort of SLE patients was followed up yearly between 1999 and 2017. AVEs were attributed to atherosclerosis based on SLE being inactive at the time of the AVE as well as typical atherosclerotic changes observed on imaging or pathology reports and/or evidence of atherosclerosis elsewhere. Analyses included descriptive statistics, rate of AVEs per 1,000 patient-years, and univariable and multivariable relative risk regression models. RESULTS: Of the 1,848 patients enrolled in the cohort, 1,710 had ≥1 follow-up visit after enrollment, for a total of 13,666 patient-years. Of these 1,710 patients, 3.6% had ≥1 AVEs attributed to atherosclerosis, for an event rate of 4.6 per 1,000 patient-years. In multivariable analyses, lower AVE rates were associated with antimalarial treatment (hazard ratio [HR] 0.54 [95% confidence interval (95% CI) 0.32-0.91]), while higher AVE rates were associated with any prior vascular event (HR 4.00 [95% CI 1.55-10.30]) and a body mass index of >40 kg/m2 (HR 2.74 [95% CI 1.04-7.18]). A prior AVE increased the risk of subsequent AVEs (HR 5.42 [95% CI 3.17-9.27], P < 0.001). CONCLUSION: The prevalence of AVEs and the rate of AVE accrual demonstrated in the present study is much lower than that seen in previously published data. This may be related to better control of both the disease activity and classic risk factors.
引用
- Urowitz MB, Gladman DD, Farewell V, et al. Accrual of Atherosclerotic Vascular Events in a Multicenter Inception Systemic Lupus Erythematosus Cohort. Arthritis Rheumatol. 2020. PMID: 32515554. doi:10.1002/art.41392
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。